Cardiovascular risk assessment:The key path toward precision preventionOACSCDCSTPCD
Cardiovascular risk assessment:The key path toward precision prevention
Jianxin Li;Xiangfeng Lu
Department of Epidemiology,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China||Key Laboratory of Cardiovascular Epidemiology,Chinese Academy of Medical Sciences,Beijing,ChinaDepartment of Epidemiology,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China||Key Laboratory of Cardiovascular Epidemiology,Chinese Academy of Medical Sciences,Beijing,China
《慢性疾病与转化医学（英文）》 2023 (4)
273-276,4
Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences,Grant/Award Numbers:2021-I2M-1-010,2019-I2M-2-003National High-Level Hospital Clinical Research Funding,Grant/Award Numbers:2022-GSP-GG-1,2022-GSP-GG-2National Clinical Research Center for Cardiovascular Diseases,Fuwai Hospital,Chinese Academy of Medical Sciences,Grant/Award Number:NCRC2020006
评论